Limited options, high costs, and a lack of novel ideas have long hindered the treatment of rare genetic disorders. Existing therapies may manage symptoms for millions of patients worldwide, but often fall short regarding long-lasting changes. Lingyi Biotech is a clinical-stage biotechnology company that's taking a different approach.

With full mobile penetration and low churn rates in the US, there's simply no business case for the major operators to do better. Enter Pronto Mobile with a completely different approach.

ed Bath & Beyond returns with a new name and honors old coupons at its first reopened store in Nashville.

Boeing CEO Kelly Ortberg halts the company's decline in his first year but now faces tough challenges to restore its former glory.

Trump urges Intel CEO Lip-Bu Tan to resign over alleged China ties, sparking national security concerns and stock dip.

epsi's new "Drips" drinks with boba, cold foam, and cotton candy are now available at Regal theaters nationwide.

NuNaturals recalls mislabeled sweeteners after FDA issues Class II warning for potential health risks.

Trump signs executive order to open 401(k) retirement plans to crypto and private equity investments.

Paramount and Skydance complete $8.4 billion merger, forming a new media giant after legal and political challenges.

Aurmor.ai is defining a new category in youth sports brain injury prevention and recovery. The company has pioneered the concept of Cumulative Neural Load (CNL), a framework for identifying, measuring, and mitigating the accumulation of repeated Motion-Induced Brain Stress (MiBS) during athletic activity.